Australian researchers have led the world in establishing adolescent cohorts that are at high risk of psychosis. The Prospective Imaging Study of Ageing (PISA) will establish Australia's first younger healthy cohort selected for high risk of dementia.
PISA is a unique collaboration of researchers using genetic, imaging and phenotypic resources, leveraging one of the world's largest existing genome-wide association study (GWAS) twin cohorts.
Cutting-edge bioinformatics, brain imaging and lifestyle monitoring is being used to address key research questions of neuropathology, "prodromal phenotype" and lifestyle risk factors in this cohort.
By shifting the focus of dementia research two decades earlier than existing cohorts, our leading research represents a decisive step forward in Australia's dementia research capacity.
The PISA team
PISA brings together internationally prominent researchers with expertise in a range of related areas:
- Professor Michael Breakspear, Systems Neuroscience, QIMR Berghofer Medical Research Institute
- Associate Professor Stephen Rose, University of Queensland Centre for Clinical Research
- Dr Christine Guo, Translational Neuroscience, QIMR Berghofer Medical Research Institute
- Associate Professor Olivier Salvado, CSIRO
- Professor Michael Weiner, University of California, San Fransisco
- Professor Gerard Byrne, University of Queensland
- Professor Osvaldo Almeida, Harry Perkins Institute of Medical Research
PISA is a joint research program of QIMR Berghofer Medical Research Institute, The University of Queensland, Queensland Health, CSIRO and The University of Western Australia.